Inovio Pharmaceuticals (INO +2.8%) bucks a lackluster tape to trade higher after Piper Jaffray...

|About: Inovio Pharmaceuticals, Inc. (INO)|By:, SA News Editor

Inovio Pharmaceuticals (INO +2.8%) bucks a lackluster tape to trade higher after Piper Jaffray initiates coverage with an Overweight. Piper notes the company is developing a novel DNA-based vaccine platform that is demonstrating "provocative" immune responses in early studies against a multiplicity of non-viral oncology targets, as well as several infectious diseases such as HIV, HCV, HPV, and the flu. The firm adds that multiple Phase II catalysts are expected this year in its HCV and leukemia platforms.